B3GALT4: Key Enzyme in Glucose Metabolism and Inflammation (G8705)

Target Name: B3GALT4

NCBI ID: G8705

B3GALT4

B3GALT4: Key Enzyme in Glucose Metabolism and Inflammation

B3GALT4 (UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase 4) is a gene that encodes a protein involved in the process of glucose metabolism. The protein is a key player in the beta-glucan pathway, which is a critical pathway for the efficient metabolism of glucose by the body. B3GALT4 plays a crucial role in the conversion of glucose to glucose-6-phosphate, which is the final step in the metabolism of glucose.

The beta-glucan pathway is a complex metabolic pathway that involves a series of enzymes that convert glucose to glucose-6-phosphate. This pathway is critical for the efficient use of glucose by the body. It is also involved in the regulation of insulin sensitivity and inflammation. B3GALT4 is one of the key enzymes in this pathway, and its function is to transfer a beta-glucan molecule to another protein called GLUT1.

B3GALT4 is a key enzyme in the beta-glucan pathway because it is responsible for the transfer of the beta-glucan molecule to GLUT1. GLUT1 is a protein that is involved in the regulation of glucose metabolism, including the metabolism of insulin resistance. It is also involved in the regulation of inflammation, and it is thought to play a role in the development of certain diseases, such as cancer.

In addition to its role in the beta-glucan pathway, B3GALT4 is also involved in the regulation of inflammation. It is part of a signaling pathway that is involved in the regulation of inflammation and immune responses. This pathway is known as the TGF-beta pathway, and it is thought to play a key role in the development of certain diseases, such as cancer.

B3GALT4 is also involved in the regulation of cell growth and differentiation. It is part of a signaling pathway that is involved in the regulation of cell growth and differentiation, and it is thought to play a key role in the development of certain diseases, such as cancer.

As a potential drug target, B3GALT4 is an attractive target for researchers because it is involved in a critical pathway for the regulation of glucose metabolism and inflammation. It is also involved in the regulation of cell growth and differentiation, which are important processes that are involved in the development of many diseases.

In conclusion, B3GALT4 is a gene that encodes a protein involved in the process of glucose metabolism and the regulation of inflammation. It is a key player in the beta-glucan pathway and is involved in the transfer of the beta-glucan molecule to GLUT1. B3GALT4 is also involved in the regulation of insulin sensitivity and inflammation, and it is a potential drug target for the treatment of a wide range of diseases. Further research is needed to fully understand the role of B3GALT4 in glucose metabolism and inflammation, and to determine its potential as a drug target.

Protein Name: Beta-1,3-galactosyltransferase 4

Functions: Involved in GM1/GD1B/GA1 ganglioside biosynthesis

The "B3GALT4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about B3GALT4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets